Gemtuzumab and chills Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #4597331-1
Gemtuzumab side effect was reported by a Pharmacist from on Feb 25, 2005. Female patient, 47 years of age, was diagnosed with leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5506674-6
Gemtuzumab side effect was reported by a Health Professional from CANADA on Oct 25, 2007. Male patient, weighting 27.56 lb, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with PETHIDINE HYDROCHLORIDE, HYDROCORTISONE, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient recovered.

Gemtuzumab Side Effects Report #5523658-2
Gemtuzumab side effect was reported by a Health Professional from CANADA on Nov 14, 2007. Male patient, weighting 27.56 lb, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with PETHIDINE HYDROCHLORIDE, HYDROCORTISONE, PARACETAMOL, DIPHENHYDRAMINE. Patient recovered.

Gemtuzumab Side Effects Report #5243941-8
Gemtuzumab side effect was reported by a Pharmacist from UNITED STATES on Feb 20, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood pressure decreased, chills, pain . Gemtuzumab dosage: unknown. During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #5023796-7
Gemtuzumab side effect was reported by a Physician from ITALY on May 23, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: balance disorder, chills, dysphagia, faecal incontinence, gait disturbance, hyporeflexia, neutropenia, peripheral sensorimotor neuropathy, pyrexia. Gemtuzumab dosage: 3 MG/M^2 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4911221-3
Gemtuzumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 05, 2004. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia, bronchopulmonary aspergillosis and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acidosis, acute myeloid leukaemia, adrenocortical insufficiency chronic, blood bicarbonate decreased, chills, coma, convulsion, dysarthria, dysphagia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, AMPHOTERICIN B. Patient died.

Gemtuzumab Side Effects Report #4853930-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2005. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, hypotension. Gemtuzumab dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4866417-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2005. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, cerebral haemorrhage, chills, gamma-glutamyltransferase increased. Gemtuzumab dosage: 13.5 MG 1X PER 1 DAY. During the same period patient was treated with MEROPEN, FUNGIZONE, VANCOMYCIN, MINOPHAGEN C, SOLCOSERYL, PRIMPERAN, FAMOTIDINE, VISCORIN. Patient died.

Gemtuzumab Side Effects Report #4867026-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, blast cell count increased, chills, haemoglobin decreased, leukopenia, neutrophil count decreased, neutrophil percentage decreased, pyrexia, thrombocytopenia. Gemtuzumab dosage: 9 MG/M2 INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #4867131-3
Gemtuzumab side effect was reported by a Physician from FRANCE on Mar 10, 2002. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, nausea , pyrexia. Gemtuzumab dosage: 9 MG/M^2. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4721926-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 08, 2005. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: axillary pain, chills, headache , infusion related reaction, oxygen saturation decreased, pyrexia. Gemtuzumab dosage: unknown. Patient recovered.

Gemtuzumab Side Effects Report #4576354-2
Gemtuzumab side effect was reported by a Physician from on Jan 31, 2005. Female patient, 52 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, cyanosis, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, POLARAMINE, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4867018-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bone pain, chills, disseminated intravascular coagulation, pyrexia. Gemtuzumab dosage: 9 MG/M2 PER DOSE INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4721976-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 07, 2005. Male patient, 41 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, flushing, infusion related reaction, pyrexia. Gemtuzumab dosage: unknown. Patient recovered.


Gemtuzumab Side Effects Report #4867739-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atrial flutter, chills, coagulopathy, diarrhoea, haemodynamic instability, herpes simplex , hypokalaemia, hypomagnesaemia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 07/11/1998.

Gemtuzumab Side Effects Report #4704478-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 30, 2005. Female patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, chills, echocardiogram abnormal, ejection fraction decreased, haemodialysis, hypokalaemia, hypokinesia, lung disorder, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ETOPOSIDE. Patient recovered.